USFDA authorises baricitinib for emergency use as monotherapy for Covid-19 patients

Retrieved on: 2021-07-30 09:00:00

Tags for this article:

Click the tags to see associated articles and topics

USFDA authorises baricitinib for emergency use as monotherapy for Covid-19 patients. View article details on hiswai:

Excerpt

... the Emergency Use Authorization (EUA) for Eli Lilly and Company and Incyte's baricitinib to treat Covid-19 patients with or without remdesivir.

Article found on: pharmaceutical-business-review.com